Dysfunctional Cortico-Limbic Activity and Connectivity in Bipolar Disorder and Li

双相情感障碍和 Li 中功能失调的皮质边缘活动和连接

基本信息

  • 批准号:
    7839353
  • 负责人:
  • 金额:
    $ 26.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This competitive revision is to enlarge the scope of the current R01 - 'Dysfunctional Corticolimbic Activity and Connectivity in Bipolar Disorder' to also study at baseline 20 bipolar disorder (BD) patients in the euthymic state (BDE) and 40 unaffected siblings (UAS) of BD patients, and is in response to Notice Number (NOT-OD- 09-058), titled: "NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications". The parent grant proposes to concurrently measure both corticoamygdalar connectivity as well as regional limbic activation in 40 unmedicated BD patients in manic phase (BDM) and 40 in the depressed phase (BDD) before and after treatment with lithium as well as 40 matched healthy control subjects. The a priori defined regions of interest are the cortical mood regulating region - ventral anterior cingulate cortex (vACC) and the amygdala. The first aim is to measure corticoamygdalar connectivity using a novel connectivity specific measure - resting state low frequency BOLD fluctuations (LFBF) correlations. The second aim is to measure amygdalar activation using an active facial emotion recognition task. Preliminary data analysis has revealed interesting results which suggest that amygdalar activation is increased and corticoamygdalar connectivity is decreased in BD compared to healthy subjects and this abnormality is state independent being present in both BDD and BDM patients. Furthermore, BD patients with a family history of mood disorder in a first degree relative have a greater decrease in corticoamygdalar connectivity than the ones without a family history. These findings suggest that corticoamygdalar connectivity and amygdalar activation in response to face task could be used as endophenotypes to investigate the genetic etiology of BD. However, to further strengthen these findings we also need to study BDE patients and UAS of BD patients. While conducting the parent study, we have screened a number of such subjects who we cannot study at this time as funding is not available. Therefore, this competing revision is being applied for to ask for a modest amount of supplement to investigate baseline corticoamygdalar activation and connectivity abnormalities in BDE and UAS of BD patients. Inclusion of these two groups will complement the overall aim of the parent study - investigating the circuit level corticoamygdalar abnormalities which may be inherent to the genetic and neurobiological etiology of BD. PUBLIC HEALTH RELEVANCE: This competing revision of the parent grant - 'Dysfunctional Corticolimbic Activity and Connectivity in Bipolar Disorder and Effect of Lithium' which is studying 40 manic, 40 bipolar depressed and 40 healthy subjects is being submitted to enlarge the scope of the parent grant to also study 20 euthymic bipolar patients and 40 unaffected siblings of bipolar patients. This study will complement the parent grant aims to elucidate the genetic and neurobiological etiology of bipolar disorder.
描述(由申请人提供):这项竞争性修订是为了扩大当前R01-“双相情感障碍的可质性皮质临床活性和连通性”的范围,以便在基线20的双相情感障碍(BD)患者(BDE)(BDE)(BDE)(BDE)(BDE)和40名未发起的患者(UAS)(UAS)(UAS)(UAS)(UAS)(UAS)(UAS)(UAS)(uAS 5)的09-0-0-0-0-0-0-0-0-0-0-0-0-0-0。标题为:“ NIH宣布为竞争性修订申请提供恢复法案的可用性”。父母赠款提议同时测量40名未经药物的BD患者(BDM)(BDM)(BDD)和40名在lithium治疗之前和之后的抑郁阶段(BDD)中,同时测量40名未经药物BD患者的皮质型乳糖连通性以及区域边缘激活。先验定义的感兴趣区域是调节皮质情绪 - 腹侧扣带回皮层(VACC)和杏仁核。第一个目的是使用一种新型连通性指标 - 静止状态低频BOLD波动(LFBF)相关性测量皮质型乳糖连通性。第二个目的是使用主动面部情感识别任务来测量杏仁核激活。初步数据分析显示了有趣的结果,这表明与健康受试者相比,BD的杏仁核激活增加,皮质型乳腺素的连通性降低,并且这种异常在BDD和BDM患者中都是独立的。此外,与没有家族史的病史相比,具有一级相对的心情障碍家族病史的BD患者的皮质型乳糖连通性降低了。这些发现表明,响应面对任务的皮质型连通性和杏仁核激活可以用作研究BD的遗传病因的内表型。但是,为了进一步加强这些发现,我们还需要研究BD患者的BDE患者和UAS。在进行家长研究时,我们已经筛选了许多此类主题,因为这些学科目前无法研究,因为没有资金。因此,这种竞争性修订被用于要求提供适度的补充剂,以研究BDE和BD患者BDE和UAS的基线皮质型和连通性异常。包括这两组的包含将补充父母研究的总体目的 - 研究电路水平的皮质型和神经生物学病因可能固有的皮质型皮质型异常。 PUBLIC HEALTH RELEVANCE: This competing revision of the parent grant - 'Dysfunctional Corticolimbic Activity and Connectivity in Bipolar Disorder and Effect of Lithium' which is studying 40 manic, 40 bipolar depressed and 40 healthy subjects is being submitted to enlarge the scope of the parent grant to also study 20 euthymic bipolar patients and 40 unaffected siblings of bipolar patients.这项研究将补充父母的旨在阐明双相情感障碍的遗传和神经生物学病因。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amit Anand其他文献

Amit Anand的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amit Anand', 18)}}的其他基金

Ketamine Treatment of Youth Suicide Attempters for Fast Reduction of Severe Suicide Risk and Facilitation of Long-term Collaborative Clinical Engagement: A Randomized Placebo Controlled Trial
氯胺酮治疗青少年自杀未遂者,可快速降低严重自杀风险并促进长期合作临床参与:一项随机安慰剂对照试验
  • 批准号:
    10471430
  • 财政年份:
    2020
  • 资助金额:
    $ 26.95万
  • 项目类别:
Ketamine Treatment of Youth Suicide Attempters for Fast Reduction of Severe Suicide Risk and Facilitation of Long-term Collaborative Clinical Engagement: A Randomized Placebo Controlled Trial
氯胺酮治疗青少年自杀未遂者,可快速降低严重自杀风险并促进长期合作临床参与:一项随机安慰剂对照试验
  • 批准号:
    10115466
  • 财政年份:
    2020
  • 资助金额:
    $ 26.95万
  • 项目类别:
Ketamine Treatment of Youth Suicide Attempters for Fast Reduction of Severe Suicide Risk and Facilitation of Long-term Collaborative Clinical Engagement: A Randomized Placebo Controlled Trial
氯胺酮治疗青少年自杀未遂者,可快速降低严重自杀风险并促进长期合作临床参与:一项随机安慰剂对照试验
  • 批准号:
    10263373
  • 财政年份:
    2020
  • 资助金额:
    $ 26.95万
  • 项目类别:
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
锂在双相情感障碍治疗中对大脑功能和结构连接体的影响
  • 批准号:
    9922362
  • 财政年份:
    2017
  • 资助金额:
    $ 26.95万
  • 项目类别:
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
锂在双相情感障碍治疗中对大脑功能和结构连接体的影响
  • 批准号:
    9402890
  • 财政年份:
    2017
  • 资助金额:
    $ 26.95万
  • 项目类别:
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
使用功能磁共振成像区分年轻人的单相和双相抑郁症
  • 批准号:
    8663708
  • 财政年份:
    2011
  • 资助金额:
    $ 26.95万
  • 项目类别:
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
使用功能磁共振成像区分年轻人的单相和双相抑郁症
  • 批准号:
    8206259
  • 财政年份:
    2011
  • 资助金额:
    $ 26.95万
  • 项目类别:
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
使用功能磁共振成像区分年轻人的单相和双相抑郁症
  • 批准号:
    8603951
  • 财政年份:
    2011
  • 资助金额:
    $ 26.95万
  • 项目类别:
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
使用功能磁共振成像区分年轻人的单相和双相抑郁症
  • 批准号:
    9065738
  • 财政年份:
    2011
  • 资助金额:
    $ 26.95万
  • 项目类别:
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
使用功能磁共振成像区分年轻人的单相和双相抑郁症
  • 批准号:
    8488479
  • 财政年份:
    2011
  • 资助金额:
    $ 26.95万
  • 项目类别:

相似海外基金

At-Home Prescription Drug Disposal System
家庭处方药处置系统
  • 批准号:
    8751814
  • 财政年份:
    2013
  • 资助金额:
    $ 26.95万
  • 项目类别:
Preclinical gene correction of hemophilia A
A型血友病临床前基因校正
  • 批准号:
    7788859
  • 财政年份:
    2007
  • 资助金额:
    $ 26.95万
  • 项目类别:
Preclinical gene correction of hemophilia A
A型血友病临床前基因校正
  • 批准号:
    8136424
  • 财政年份:
    2007
  • 资助金额:
    $ 26.95万
  • 项目类别:
Preclinical gene correction of hemophilia A
A型血友病临床前基因校正
  • 批准号:
    7393720
  • 财政年份:
    2007
  • 资助金额:
    $ 26.95万
  • 项目类别:
Preclinical gene correction of hemophilia A
A型血友病临床前基因校正
  • 批准号:
    7263382
  • 财政年份:
    2007
  • 资助金额:
    $ 26.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了